BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Autoimmunity
,
Phenobarbital
,
rs3825942
,
FABP1
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RNA polymerase I core binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Treacher Collins syndrome
Perforation of tympanic membrane
Liver transplant disorder
Methicillin resistant Staphylococcus aureus infection
Contact dermatitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
2,3-dimethoxy-1,4-naphthoquinone
epoxomicin
TNF-Related Apoptosis-Inducing Ligand
Ketanserin
Prolactin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
ARL4C
HDLBP
LAT
CAMK1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for RNA polymerase I core binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II…
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in R…
Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients
Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients
Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Re…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ